StockData
CG Oncology, Inc. logo

CG Oncology, Inc. (CGON) stock

CGONNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$78.94−5.84 (-6.89%)

Close on Nov 17, 2026Market cap $7.00BP/E –Yield –

CG Oncology total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

CG Oncology's total debt was $3.00M at Sep 30, 2026. For fiscal 2025 it was $3.00M.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.00M–
FY2024Dec 31, 2024$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$3.00M0.0%
Q2 FY2026Jun 30, 2026$3.00M–
Q1 FY2026Mar 31, 2026$3.00M–
Q4 FY2025Dec 31, 2025$3.00M–
Q3 FY2025Sep 30, 2025$3.00M–
Q4 FY2024Dec 31, 2024$0–

More CG Oncology figures

See a number that looks wrong?